Synthesis and biological evaluation of positron emission tomography radiotracers targeting serotonin 4 receptors in brain: [18F]MNI-698 and [18F]MNI-699 von Caillé, Fabien, Morley, Thomas J., Tavares, Adriana Alexandre S., Papin, Caroline, Twardy, Nicole M., Alagille, David, Lee, H. Sharon, Baldwin, Ronald M., Seibyl, John P., Barret, Olivier, Tamagnan, Gilles D.

Volltext

Automated one-step radiosynthesis of the CB1 receptor imaging agent [18F]MK-9470 von Thomae, David, Morley, Thomas J., Hamill, Terence, Carroll, Vincent M., Papin, Caroline, Twardy, Nicole M., Lee, H. Sharon, Hargreaves, Richard, Baldwin, Ronald M., Tamagnan, Gilles, Alagille, David

Volltext

Automated one‐step radiosynthesis of the CB 1 receptor imaging agent [ 18 F]MK‐9470 von Thomae, David, Morley, Thomas J., Hamill, Terence, Carroll, Vincent M., Papin, Caroline, Twardy, Nicole M., Lee, H. Sharon, Hargreaves, Richard, Baldwin, Ronald M., Tamagnan, Gilles, Alagille, David

Volltext

Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia von Brown, Jennifer R., Eichhorst, Barbara, Hillmen, Peter, Jurczak, Wojciech, Kaźmierczak, Maciej, Lamanna, Nicole, O’Brien, Susan M., Tam, Constantine S., Qiu, Lugui, Zhou, Keshu, Simkovic, Martin, Mayer, Jiri, Gillespie-Twardy, Amanda, Ferrajoli, Alessandra, Ganly, Peter S., Weinkove, Robert, Grosicki, Sebastian, Mital, Andrzej, Robak, Tadeusz, Osterborg, Anders, Yimer, Habte A., Salmi, Tommi, Wang, Megan-Der-Yu, Fu, Lina, Li, Jessica, Wu, Kenneth, Cohen, Aileen, Shadman, Mazyar

Volltext

Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial von Hillmen, Peter, Eichhorst, Barbara, Brown, Jennifer R, Lamanna, Nicole, O'Brien, Susan M, Tam, Constantine S, Qiu, Lugui, Kazmierczak, Maciej, Zhou, Keshu, Šimkovič, Martin, Mayer, Jiří, Gillespie-Twardy, Amanda, Shadman, Mazyar, Ferrajoli, Alessandra, Ganly, Peter S, Weinkove, Robert, Grosicki, Sebastian, Mital, Andrzej, Robak, Tadeusz, Österborg, Anders, Yimer, Habte A, Salmi, Tommi, Ji, Meng, Yecies, Jessica, Idoine, Adam, Wu, Kenneth, Huang, Jane, Jurczak, Wojciech

Volltext

Extended Follow-up of ALPINE Randomized Phase 3 Study Confirms Sustained Superior Progression-Free Survival of Zanubrutinib Versus Ibrutinib for Treatment of Relapsed/Refractory Ch... von Brown, Jennifer R., Eichhorst, Barbara F., Lamanna, Nicole, O'Brien, Susan M., Tam, Constantine S., Qiu, Luqui, Kaźmierczak, Maciej, Jurczak, Wojciech, Zhou, Keshu, Simkovic, Martin, Mayer, Jiri, Gillespie-Twardy, Amanda L., Ferrajoli, Alessandra, Ganly, Peter S., Weinkove, Robert, Grosicki, Sebastian, Mital, Andrzej, Robak, Tadeusz, Osterborg, Anders, Yimer, Habte A., Wang, Megan (Der Yu), Salmi, Tommi, Wang, Liping, Li, Jessica, Wu, Kenneth, Cohen, Aileen Cleary, Shadman, Mazyar

Volltext

Zanubrutinib Demonstrates Superior Progression-Free Survival (PFS) Compared with Ibrutinib for Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic L... von Brown, Jennifer R., Eichhorst, Barbara, Hillmen, Peter, Lamanna, Nicole, O'Brien, Susan M., Tam, Constantine S., Qiu, Lugui, Kaźmierczak, Maciej, Jurczak, Wojciech, Zhou, Keshu, Šimkovič, Martin, Mayer, Jiri, Gillespie-Twardy, Amanda L., Ferrajoli, Alessandra, Ganly, Peter S., Weinkove, Robert, Grosicki, Sebastian, Mital, Andrzej, Robak, Tadeusz, Österborg, Anders, Yimer, Habte A., Salmi, Tommi, Wang, Megan (Der Yu), Fu, Lina, Li, Jessica, Wu, Kenneth, Cohen, Aileen, Shadman, Mazyar

Volltext

Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment von Brown, JR, Eichhorst, B, Hillmen, P, Jurczak, W, Kazmierczak, M, Lamanna, N, O'Brien, SM, Tam, CS, Qiu, LG, Zhou, KS, Simkovic, M, Mayer, J, Gillespie-Twardy, A, Ferrajoli, A, Ganly, PS, Weinkove, R, Grosicki, S, Mital, A, Robak, T, Osterborg, A, Yimer, HA, Salmi, T, Wang, MDY, Fu, LN, Li, J, Wu, KN, Cohen, A, Shadman, M

Volltext